account_balance
Investment manager · 13F filer · SEC CIK 1854794
Patient Capital Management, LLC
Reported value$2.98Bas of Sep 30, 2026
Positions39 3 new, 3 sold out
Top 10 weight53.2%RPRX alone is 7%
FiledNov 1243 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
RPRXRoyalty Pharma PLC
6.7%Trimmed −5%
CCitigroup Inc
6.0%
GOOGLAlphabet Inc
6.0%
AMZNAmazon Com Inc
5.7%
NVDANvidia Corporation
5.4%
UNHUnitedhealth Group Inc
5.2%Trimmed −3%
PGENPrecigen Inc
5.2%Trimmed −6%
METAMeta Platforms Inc
4.4%Added +6%
QXOQxo Inc
4.3%Added +53%
CHYMChime Finl Inc
4.2%Added +16%
ETEnergy Transfer L P
4.0%
ADBE3.2%RPRX6.7%C6.0%GOOGL6.0%
AMZNAmazon Com Inc
5.7%
NVDANvidia Corporation
5.4%
UNHUnitedhealth Group Inc
5.2%Trimmed −3%
PGEN5.2%META4.4%QXO4.3%CHYM4.2%ET4.0%ADBE3.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
RPRX Royalty Pharma PLC 6.7% Trimmed −5%C Citigroup Inc 6.0% HeldGOOGL Alphabet Inc 6.0% HeldAMZN Amazon Com Inc 5.7% HeldNVDA Nvidia Corporation 5.4% HeldUNH Unitedhealth Group Inc 5.2% Trimmed −3%PGEN Precigen Inc 5.2% Trimmed −6%META Meta Platforms Inc 4.4% Added +6%QXO Qxo Inc 4.3% Added +53%CHYM Chime Finl Inc 4.2% Added +16%ET Energy Transfer L P 4.0% HeldADBE Adobe Inc 3.2% Added +11%
What changed